PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Vita-Salute San Raffaele, Milan, Italy.\', \'Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.\', \'Division of Endocrinology, Ospedale Maggiore, Bologna, Italy.\', \'Department of Translational Medicine, Lund University, Malmö, Sweden.\', \'Endocrinology Unit, Department of Experimental, Clinical and Biomedical Sciences \'Mario Serio\', University of Florence, Florence, Italy.\', \'Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.\', \'Obstetrics and Gynecology Section of the Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy.\', \'Department of Urology, University of Ioannina School of Medicine, Ioannina, Greece.\', \'Andrology, Female Endocrinology and Gender Incongruence Unit, Department of Experimental, Clinical and Biomedical Sciences \'Mario Serio\', University of Florence, Florence, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/andr.12811
?:doi
?:hasPublicationType
?:journal
  • Andrology
is ?:pmid of
?:pmid
?:pmid
  • 32369678
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.154
?:rankingScore_hIndex
  • 24
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all